Allergy Flashcards

1
Q

Why aren’t antihistamines useful in treating asthma?

A
  • some asthmatics are allergic
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where are mast cells found?

A
  • Predominantly in surfaces that engage with external environment
    • skin, lung, & gut
  • commonly associated with blood vessels, nerves, glands in the parenchyma of all organs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What triggers mast cells to be activated?

A
  • polybasic drugs (positively charged)
    • morphine, vancomycin
  • allergens via IgE
  • mechanical stimulants
    • heat, cold, UV light
  • polybasic peptides in stings, venom, bites
  • hyperosmolarity of airway surface fluid in exercise
    • exercise induced bronchospasm (airway drying when Ve goes up)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is mast cell degranulation induced by allergens?

A
  • cross-linking of IgE with mast cell FcER1
  • requires antigen-specific IgE
    • overproduced in atopic subjects to both general and specific allergens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the mechanism of mast cell degranulation?

A
  • adjacent IgE bind to allergen
  • causes FcER1 receptors to cluster
  • beta and gamma chains on cytoplasmic FcER1 tails (ITAMS) are phosphorylated by Lyn (a Syk/spleen tyrosine kinase)
    • **ITAMS have no integral kinase activity until they are cross-linked with allergen and the receptors migrate to lipid rafts
  • leads to recruitment and activation of other cellular tyrosine kinases
  • phospholipase C is activated (and other signalling enzymes)
    • releases diacylglycerol
    • inositol triphosphate
    • these + protein kinase C and Ca2+, respectively, cause explosive degranulation
  • takes about 30-45 seconds
    • ​this is only the quick part; histamine is released immediately but there are other phases that generate response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What do mast cell granules contain?

A
  • histamine
  • heparin
  • VEGF
  • FGF
  • preformed cytokines (for immediate action)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the immediate mediators released by mast cell degranulation?

A
  • preformed mediators, ~30-45 seconds
    • histamine
    • heparin (anticoagulant)
    • tryptase (protease activator receptor II ligand)
    • TNFa
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the rapid (second) mediators released on mast cell degranulation?

A
  • rapid mediators, ~2-5 minutes, peak ~10-30 minutes but made at elevated levels for next several hours
    • mobilized arachidonic acid leads to formation of PGD2 (by COX) and cysteinyl leukotrienes (5-lipox)
    • both are potent bronchoconstrictors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the slow mediators released by mast cell degranulation?

A
  • related to transcriptional events (hence slow), takes some hours
  • perpetuate the allergic response
  • cytokines:
    • IL-4
    • IL-5
    • GM-CSF
  • promote infiltration of eosinophils and T-cells, attract more mast cells
    • sensitizes and activates site for many days post-event
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the effects of immediately released histamine?

A
  • acts on H1 receptors
    • pain and itch via sensory nerve activation
    • bronchospasm of smooth muscle
    • increased mucous secretion
    • vasodilation (if systemic, can cause hypotension)
    • endothelial retraction causing increased vascular leak, hypovolemia
    • positive ionotropic and chronotropic effects on the heart (H2)
    • increased gastric acid secretion, causing colic pain (H2)
    • promotes wakefullness in CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the action of leukotrienes in allergic/anaphylactic response?

A
  • potent bronchoconstrictors (LTC4, LTD4, LTE4) active at the CysLT1 receptor
  • reinforce systemic hypotension caused by histamine
  • vasodilation in skeletal muscle
  • diminsh cardiac output
  • cause vascular leak and potentially hypovolemia (in conjunction with other mediators that cause vascular leak and loss of tone in vascular muscles)
  • airway obstruction in asthma
    • cause vasoconstriction, increased mucous production, oedema
  • promote dilation and leakiness of nasal vessels (mucous and oedema) in allergic rhinitis/hayfever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the effects of delayed release cytokines by mast cell degranulation?

A
  • act through inducing changes in gene expression in target cells
  • recruitment of inflammatory cells (can be over several days)
  • structural changes as a chronic allergic response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the targets of anti-inflammatory glucocorticoids from mast cell degranulation?

A
  • many of the cytokines released in the delayed/long-term response:
    • IL-1, TNF, IL-5 (predominantly)
    • IL-4 (not as tightly)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the endogenous inhibitors of mast cell activation?

A
  • PGE2
  • adrenaline
    • acts on beta2 receptors to +cAMP and +circulating cortisol
  • minor in those who suffer from allergic disease; must rely on pharmacological inhibitors in these pt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the pharmacological inhibitors of mast cell activation?

A
  • disodium cromoglycate and nedocromil sodium
  • weak anti-inflammatory agents
  • not absorbed, tf:
    • applied topically
    • does not access systemic circulation (well-tolerated)
    • must be taken preventatively
  • not useful in all patients
  • reduce mast cell activation, neurogenic inflamation, and eosinophil activation
  • may cause release of annexin-1, a protein mediatior of glucocorticoid activity
    • turns off ongoing inflammatory responses
  • used in tx of allergic responses of mucosal surfaces (nasal, airway, gut)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the action of omalizumab in inhbiting mast cell activation?

A
  • humanized Ig directed against Fc portion of IgE
  • reduces sensitization of mast cells by hindering interaction between Fc portion of IgE where it binds with the FcER1 on the mast cell
    • IgE must be bound to an immunocompetent cell to elicit an effect
  • decreases levels of IgE and FcER1
  • must be given subcutaneously and repeatedly
  • expensive
  • blunts effects of histamine and other mediators to alleviate bronchoconstriction and reduction in FEV1
17
Q

Why aren’t NSAIDs and COX-2 inhibitors used as anti-allergic agents?

A
  • they produce no benefit in asthma or hayfever
  • may provoke symptoms in ~10% of asthmatics & hayfever sufferers who have excessive production of leukotrienes
    • e.g. aspirin-induced asthma, which is instead tx with leukotriene receptor antagonists (LTRA)
18
Q

What is the beneficial effect of using glucocorticoids in allergy?

A
  • suppression of mast cell responsiveness
    • less reactive to allergens
    • suppresion of leukotriene production and cytokine production
19
Q

Glucocorticoids are used as anti-inflammatory agents in

A
  • asthma (budesonide)
  • hypersensitvity states/allergic reactions
    • skin, eye, etc. (topical - beclomethasone diproprionate)
    • systemic anaphylaxis (oral or intramuscular - hydrocortisone)
20
Q

What are the indications for H1 receptor antagonists in allergic disease?

A
  • urticaria
  • atopic dermatitis (w/steroids)
  • hayfever (allergic rhinitis)
  • anaphylaxis and angioedema (w/adrenaline)
  • bites and stings
  • motion sickness via muscarinic antagonist activity
  • they are NOT useful in tx of colds or asthma
21
Q

What are the three classes/generations of H1 receptor antagonists (anti-histamines)?

A
  1. sedative
    • chlorphoeniramine, promethazine
  2. non-sedative (withdrawn: sudden ventricular arrhythmia related to prolonged QT segments)
    • terfenadine, astemizole
  3. newer non-sedative (less-sedative)
    • cetirizine, loratidine
22
Q

What is the action of cysteinyl leukotriene receptor antagonists?

A
  • block actions of cysLTs that cause spasm of the muscle and increased mucous secretions
  • e.g. zafirlukast, montelukast (prophylactic)
  • cause modest bronchodilation
  • orally active
  • few adverse effects due to leukotrienes being patho-specific (inflammation roles only)
  • commonly used:
    • to tx aspirin and exercise-induced asthma
    • in combo with other therapy eg GCS/beta2-agonists
23
Q

What are the classes of anti-allergic drugs?

A
  • anti-histamines
    • allergic responses of mucosal surfaces, not asthma or colds
    • urticaria, atopic dermatitis, hayfever, anaphylaxis, angioedema, bites, stings
  • glucocorticoids
    • anti-inflammatories in:
      • asthma, hypersensitivity states (allergic reactions and anaphylaxis)
  • cysteinyl leukotriene receptor antagonists
    • aspirin-induced and exercise-induced asthma, hayfever
  • NOT NSAIDs, COX-2 inhibitors